Morgan Stanley initiates Octave Intelligence (OCTV) with Equal-weight and a $21 target—key IPO details, ARR metrics, and ...
Aug 12, 2026, 5:08 PM ETOctave Intelligence plc (OCTLF) Stock, OCTV StockAI-Generated Earnings Calls Insights Earnings Call Insights: Octave Intelligence plc (OCTV) Q2 2026 "For the third quarter of ...
The average one-year price target for Octave Specialty Group (NYSE:OSG) has been revised to $13.70 / share. This is a decrease of 11.87% from the prior estimate of $15.54 dated August 25, 2026. These ...
Fintel reports that on September 17, 2026, Morgan Stanley initiated coverage of Octave Intelligence (NASDAQGS:OCTV) with a Equal-Weight recommendation. Prior to this coverage initiation, the company's ...
HYDERABAD, India, March 2, 2026 /PRNewswire/ -- Octave, the potential software spin-off from Hexagon AB, today unveiled its new brand identity, marking a major step toward its transition into an ...
Nasdaq-listed Octave Intelligence plc on Wednesday (August 26, 2026) opened its global technology and innovation centre, a 2 lakh sq ft facility, in Hyderabad. It will be a key technology and ...
Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases, today ...
Octave Intelligence has inaugurated a 2-lakh-sq-ft technology centre in Hyderabad and plans to scale its workforce to 2,000 engineers across software, AI, data and cloud ...
The centre will focus on software engineering, artificial intelligence (AI), data, cloud and product development, and will contribute to Octave’s global technology and innovation operations.
Octave Specialty Group, Inc. (“Octave”) (NYSE: OSG), a global specialty insurance firm, today announced that Philip Stefano has joined the company as Managing Director, Head of Investor Relations.
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, a leading precision care company focused on delivering a new standard of care for multiple sclerosis (MS) and other neurodegenerative diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results